[ad_1]
It suspended testing of the US pharmaceutical giant Johnson and Johnson’s coronavirus vaccine on Monday after an unexplained health problem occurred in one of the test subjects, the MTI wrote.
The company is one of those competing to be the first to produce a vaccine against the disease. Trials are currently underway in the final part of a three-phase clinical trial in which the vaccine was administered to thousands of people to test its efficacy and safe use.
Johnson and Johnson said last month that it intends to involve 60,000 people on three continents in the third phase of the experiments. However, a report said Monday that diseases, even serious ones, usually occur during a clinical trial and are expected to show up in large numbers in larger trials.
It was also found that there is a difference in announcing the suspension of trials at the trial level than when a health authority orders the same. The company highlighted its strong commitment to the safe use of the vaccine. It also noted that the subject’s illness was being examined by company doctors, as well as health professionals from independent inspection bodies.
Featured Image: Getty Images
[ad_2]
